Probiotics and prebiotics in preterm infants: Where are we? Where are we going?☆
Introduction
Over the past decade or so, we have witnessed an explosion of new information pertaining to the possible role of gut microbiota in health and disease. This has led to an interest in the development of strategies aimed at manipulating bacterial colonization, including the administration of probiotics or prebiotics or a combination of both (synbiotics). These products are currently gaining worldwide popularity and are increasingly being used in the pediatric population. However, uncertainty exists regarding the efficacy and safety of their use in preterm infants.
The purpose of this paper is to summarize the literature concerning the effects of administering probiotics and/or prebiotics to preterm infants primarily on clinically relevant health outcomes. Literature searches of MEDLINE, the Cochrane Database of Systematic Reviews, and the Cochrane Controlled Trials Register were performed in August 2008. Search terms included subject headings and text words relevant to probiotics and/or prebiotics and preterm infants. Supplemental searches were conducted through July 2009. The searches were limited to randomized controlled trials (RCTs) or their systematic reviews or meta-analyses. For outcomes of interest that have previously been reviewed systematically, a summary of the findings from those reviews is presented. In addition, data from primary studies published subsequent to those reviews are assessed.
Section snippets
Probiotics
Probiotics are defined as ‘live microorganisms which when administered in adequate amounts confer a health benefit on the host’ [1]. The rationale for probiotic supplementation of preterm infants is based on data demonstrating differences in the establishment of the intestinal microbiota in preterm infants [2], [3], [4], [5], [6]. Compared with healthy, full-term infants, the intestinal microbiota in preterm infants features a low number of species, with typically only 3 bacterial species found
Prebiotics
The term ‘prebiotic’ was introduced by Gibson and Roberfroid in 1995, who defined prebiotics as ‘nondigestible food components that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon and thereby improving host health’ [40]. Oligosaccharides that are contained in human breast milk are considered to be the prototype of prebiotics, since they have been shown to facilitate the growth of bifidobacteria and
Synbiotics
The term ‘synbiotic’ is used ‘when a product contains both probiotics and prebiotics’ [53]. In a recently published RCT [54], 90 preterm infants received a dietary supplement containing 2 lactobacillus species plus fructooligosaccharides, a supplement containing several species of lactobacilli and bifidobacteria plus fructooligosaccharides, or placebo (a dilute preparation of Pregestamil formula) twice daily for 28 days or until discharge if earlier. The study found that preterm infants who
Safety issues
In 2004, the ESPGHAN Committee on Nutrition commented on the probiotic bacteria in dietetic products for infants and stated that the probiotics used thus far in clinical trials can be generally considered as safe. However surveillance regarding the detection of possible side effects, such as cases of infection in high-risk groups for which there is very little systematic evidence available, is needed. The Committee concluded that the available data are not sufficient to support the safety of
Conclusions
So where are we now, and where are we going? The magnitude of the problem of prematurity worldwide justifies any attempt at the prevention of morbidity and mortality in preterm infants. Probiotics and prebiotics have the potential to prevent and treat many disorders in preterm infants. To date, the most promising application is the prevention of NEC by the administration of probiotics. Many other benefits of administering probiotics and/or prebiotics to preterm infants are, however, largely
Role of the funding source
No funding source was involved in this study.
Conflict of interest
None declared.
References (56)
Epidemiology of necrotizing enterocolitis
Clin Perinatol
(1994)- et al.
Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials
Lancet
(2007) - et al.
Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates
J Pediatr
(2005) - et al.
Enteral feeding of premature neonates with Saccharomyces boulardii
Early Hum Dev
(2003) - et al.
The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants
Early Hum Dev
(2007) - et al.
Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial
Am J Clin Nutr
(2009) - et al.
Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis
Lancet
(2003) - et al.
The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns
J Pediatr
(2008) - et al.
Dietary modulation of the human colonic microbiota. Introducing the concept of prebiotics
J Nutr
(1995) - et al.
Protective nutrients and bacterial colonization in the immature human gut
Adv Pediatr
(1999)
Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and prebiotics
Gastroenterology
Prebiotic supplementation of formula in preterm neonates: a systematic review and meta-analysis of randomised controlled trials
Clin Nutr
The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants
Early Hum Dev
Development of gut colonisation in pre-term neonates
J Med Microbiol
Stool microflora in extremely low birthweight infants
Arch Dis Child Fetal Neonatal Ed
Fecal microbial community in preterm infants
J Pediatr Gastroenterol Nutr
Stool microflora in extremely low birthweight infants
Arch Dis Child Fetal Neonatal Ed
Fecal microbial community in preterm infants
J Pediatr Gastroenterol Nutr
Development of gut colonisation in pre-term neonates
J Med Microbiol
Stool microflora in extremely low birthweight infants
Arch Dis Child Fetal Neonatal Ed
Fecal microbial community in preterm infants
J Pediatr Gastroenterol Nutr
Epidemiology of neonatal necrotizing enterocolitis: a population-based study
Paediatr Perinat Epidemiol
Necrotizing enterocolitis in the full-term neonate
J Paediatr Child Health
Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts
Pediatr Dev Pathol
Neonatal necrotizing enterocolitis: possible role of probiotic supplementation
J Pediatr Gastroenterol Nutr
Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm neonates. A prospective double blind study
Biol Neonate
Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight neonates
Pediatrics
Cited by (27)
Bacterial colonization and gut development in preterm neonates
2012, Early Human DevelopmentCitation Excerpt :Despite limited evidence for a role of specific bacteria in NEC development, numerous attempts have been made to modify intestinal colonization with probiotic bacteria to decrease the risk of NEC. Several meta analyses [76–79] and a recently updated Cochrane analysis [80,81] claim that interventions with probiotics mostly from the genera of Lactobacilli and Bifidobacteria are safe for preterm infants and reduce the risk of NEC. Based on animal studies [27,82,83], these probiotics are hypothesized to exert their effect through competitive exclusion of potential pathogens and stimulation of the host immune system [4,5,84], improved regulation of apoptosis and cyto-protective responses [85] and better gut barrier functions [82,83].
Fermented whey beverages: A review of process fundamentals, recent developments and nutritional potential
2023, International Journal of Dairy TechnologyProbiotics to prevent necrotizing enterocolitis and reduce mortality in neonates: A meta-analysis
2023, Medicine (United States)
- ☆
Presented at the 2nd International Conference on ‘Nutrition of the preterm infant: current issues’, Rome, 18–19 September 2008. The Symposium Director was Professor Vittorio Vigi.